This topic contains a solution. Click here to go to the answer

Author Question: Which agent commonly used to treat intermittent claudication has the greatest inhibition of platelet ... (Read 93 times)

biggirl4568

  • Hero Member
  • *****
  • Posts: 551
Which agent commonly used to treat intermittent claudication has the greatest inhibition of platelet aggregation?
 
  1. Cilostazol (Pletal)
  2. Aspirin
  3. Dipyridamole (Persantine)
  4. Ticlopidine (Ticlid)

Question 2

One difference between alteplase and streptokinase is that alteplase:
 
  1. will not cause allergic reactions.
  2. causes less intracranial bleeding.
  3. causes more hypotension.
  4. costs less than streptokinase.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

josephsuarez

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

Correct Answer: 1

Answer to Question 2

Correct Answer: 1




biggirl4568

  • Member
  • Posts: 551
Reply 2 on: Jul 23, 2018
Wow, this really help


parshano

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

Green tea is able to stop the scent of garlic or onion from causing bad breath.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library